These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 7068619)
1. Apoprotein E suppresses phytohemagglutinin-activated phospholipid turnover in peripheral blood mononuclear cells. Avila EM; Holdsworth G; Sasaki N; Jackson RL; Harmony JA J Biol Chem; 1982 May; 257(10):5900-9. PubMed ID: 7068619 [TBL] [Abstract][Full Text] [Related]
2. Immunoregulatory plasma lipoproteins. Role of apoprotein E and apoprotein B. Hui DY; Harmony JA; Innerarity TL; Mahley RW J Biol Chem; 1980 Dec; 255(24):11775-81. PubMed ID: 7440569 [TBL] [Abstract][Full Text] [Related]
3. Low-density lipoprotein receptor binding determinants switch from apolipoprotein E to apolipoprotein B during conversion of hypertriglyceridemic very-low-density lipoprotein to low-density lipoproteins. Bradley WA; Hwang SL; Karlin JB; Lin AH; Prasad SC; Gotto AM; Gianturco SH J Biol Chem; 1984 Dec; 259(23):14728-35. PubMed ID: 6501314 [TBL] [Abstract][Full Text] [Related]
4. Effect of heparin-induced lipolysis on the distribution of apolipoprotein e among lipoprotein subclasses. Studies with patients deficient in hepatic triglyceride lipase and lipoprotein lipase. Rubinstein A; Gibson JC; Paterniti JR; Kakis G; Little A; Ginsberg HN; Brown WV J Clin Invest; 1985 Feb; 75(2):710-21. PubMed ID: 3973025 [TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo. Ginsberg HN; Le NA; Goldberg IJ; Gibson JC; Rubinstein A; Wang-Iverson P; Norum R; Brown WV J Clin Invest; 1986 Nov; 78(5):1287-95. PubMed ID: 3095375 [TBL] [Abstract][Full Text] [Related]
6. Studies of the lipid binding characteristics of the apolipoproteins from human high density lipoprotein. II. Calorimetry of the binding of apo AI and apo AII with phospholipids. Rosseneu M; Soetewey F; Middelhoff G; Peeters H; Brown WV Biochim Biophys Acta; 1976 Jul; 441(1):68-80. PubMed ID: 182250 [TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein and lipid composition of plasma lipoproteins in neonates during the first month of life. van Biervliet JP; Rosseneu M; Bury J; Caster H; Stul MS; Lamote R Pediatr Res; 1986 Apr; 20(4):324-8. PubMed ID: 3085061 [TBL] [Abstract][Full Text] [Related]
8. Cholesterol accumulation in J774 macrophages induced by triglyceride-rich lipoproteins. Comparison of very low density lipoprotein from subjects with type III, IV, and V hyperlipoproteinemias. Huff MW; Evans AJ; Sawyez CG; Wolfe BM; Nestel PJ Arterioscler Thromb; 1991; 11(2):221-33. PubMed ID: 1998641 [TBL] [Abstract][Full Text] [Related]
9. Activation of fibrinolysis by apolipoproteins of high density lipoproteins in man. Saku K; Ahmad M; Glas-Greenwalt P; Kashyap ML Thromb Res; 1985 Jul; 39(1):1-8. PubMed ID: 4035643 [TBL] [Abstract][Full Text] [Related]
10. Hepatic secretion of lipoproteins in the rat and the effect of experimental nephrosis. Marsh JB; Sparks CE J Clin Invest; 1979 Nov; 64(5):1229-37. PubMed ID: 227928 [TBL] [Abstract][Full Text] [Related]
11. Mechanism of action of gemfibrozil on lipoprotein metabolism. Saku K; Gartside PS; Hynd BA; Kashyap ML J Clin Invest; 1985 May; 75(5):1702-12. PubMed ID: 3923042 [TBL] [Abstract][Full Text] [Related]
12. Role of apolipoprotein E in the lipolytic conversion of beta-very low density lipoproteins to low density lipoproteins in type III hyperlipoproteinemia. Ehnholm C; Mahley RW; Chappell DA; Weisgraber KH; Ludwig E; Witztum JL Proc Natl Acad Sci U S A; 1984 Sep; 81(17):5566-70. PubMed ID: 6591204 [TBL] [Abstract][Full Text] [Related]
13. Relationships between the metabolism of high-density and very-low-density lipoproteins in man: studies of apolipoprotein kinetics and adipose tissue lipoprotein lipase activity. Magill P; Rao SN; Miller NE; Nicoll A; Brunzell J; St Hilaire J; Lewis B Eur J Clin Invest; 1982 Apr; 12(2):113-20. PubMed ID: 6807682 [TBL] [Abstract][Full Text] [Related]
14. Distribution of apolipoprotein E isoforms between very low and high density lipoproteins of normal subjects and hyperlipidemic patients with special reference to type III hyperlipidemia. Holmquist L Acta Med Scand; 1984; 215(2):113-20. PubMed ID: 6702490 [TBL] [Abstract][Full Text] [Related]
15. Cord blood plasma lipoproteins inhibit mitogen-stimulated lymphocyte proliferation. Curtiss LK; Forte TM; Davis PA J Immunol; 1984 Sep; 133(3):1379-84. PubMed ID: 6430997 [TBL] [Abstract][Full Text] [Related]
16. Receptor binding activity of high-density lipoproteins containing apoprotein E from abetalipoproteinemic and normal neonate plasma. Innerarity TL; Bersot TP; Arnold KS; Weisgraber KH; Davis PA; Forte TM; Mahley RW Metabolism; 1984 Feb; 33(2):186-95. PubMed ID: 6319954 [TBL] [Abstract][Full Text] [Related]
17. Familial dysbetalipoproteinemia. Abnormal binding of mutant apoprotein E to low density lipoprotein receptors of human fibroblasts and membranes from liver and adrenal of rats, rabbits, and cows. Schneider WJ; Kovanen PT; Brown MS; Goldstein JL; Utermann G; Weber W; Havel RJ; Kotite L; Kane JP; Innerarity TL; Mahley RW J Clin Invest; 1981 Oct; 68(4):1075-85. PubMed ID: 6270194 [TBL] [Abstract][Full Text] [Related]
18. The surface charge of apolipoproteins, phospholipid liposomes, and human very low density lipoproteins. Heuck CC; Daerr W; Haberbosch W; Horn D; Lüddecke E J Biol Chem; 1983 Jul; 258(13):8317-22. PubMed ID: 6408088 [TBL] [Abstract][Full Text] [Related]
19. [Apoproteins in dyslipoproteinemia (author's transl)]. Dewailly P Diabete Metab; 1981 Mar; 7(1):51-61. PubMed ID: 6786929 [TBL] [Abstract][Full Text] [Related]
20. Metabolism of apolipoproteins C-II, C-III, and B in hypertriglyceridemic men. Changes after heparin-induced lipolysis. Huff MW; Breckenridge WC; Strong WL; Wolfe BM Arteriosclerosis; 1988; 8(5):471-9. PubMed ID: 3190554 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]